14 April 2022>: Database Analysis
Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
Zhi-Zhao Li 12ABCDEF , Xin Du 2A , Nian Liu 2A , Xue-yuan Guo 2A , Chao Jiang 2A , Liu He 2C , Shi-jun Xia 2A , Wei Wang 2A , Ri-bo Tang 2A , San-shuai Chang 2A , Rong-hui Yu 2A , De-yong Long 2A , Rong Bai 2A , Cai-hua Sang 2A , Song-nan Li 2A , Jian-zeng Dong 2A , Chang-sheng Ma 2A*DOI: 10.12659/MSM.934747
Med Sci Monit 2022; 28:e934747
Figure 1 (A1, A2) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile (Q) of LDL-C without oral anticoagulants (OAC). (Q1, <1.95; Q2, 1.95–2.51; Q3, 2.52–3.09; and Q4 >3.09 mmol/L). (B) Stroke/thromboembolism and cardiovascular mortality-free survival rate by quartile of LDL-C with OAC.